SS Innovations International Inc. (NASDAQ: SSII) is strengthening its position in the emerging telerobotic surgery market as advances in surgical robotics and communications technology create new opportunities for remote medical procedures. The company’s SSi Mantra surgical robotic system has supported 195 robotic telesurgeries as of September 28, 2026, including cardiac procedures and operations performed across significant geographic distances, according to a company update.
The milestone matters because telesurgery could extend specialized surgical expertise to underserved regions, reducing the need for patients to travel long distances for complex operations. Alongside its telesurgery developments, SS Innovations reported a 45% increase in its installed base to 244 systems across 12 countries, with cumulative surgical procedures reaching 14,503 and approximately 1,500 physicians trained on the platform. That installed base growth suggests hospitals and surgical teams are increasingly adopting the SSi Mantra system for a range of procedures, not just pilot programs.
Recent international expansion includes new robotic cardiac surgery programs in Colombia, Sri Lanka, and India. These programs are notable because cardiac surgery is among the most complex surgical disciplines, and successful remote cardiac procedures would demonstrate the potential of telerobotic systems in high-stakes environments. The company is also pursuing U.S. FDA clearance and European Union CE marking to support entry into additional markets. Regulatory approvals in these regions would be critical for broader commercialization and could open access to some of the world’s largest healthcare markets.
For investors and industry observers, the numbers provide a tangible measure of traction in a competitive field. The cumulative procedure count and physician training figures indicate that the platform is being used regularly, which can drive further adoption as clinical experience accumulates. The full article is available at https://ibn.fm/S3TFq. More information about the company can be found at SSInnovations.com, and the latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII.
The announcement was distributed through TechMediaWire, a specialized communications platform focused on pioneering public and private companies driving the future of technology. TechMediaWire is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries. The platform also provides article and editorial syndication to 5,000+ outlets, enhanced press release enhancement to ensure maximum impact, and social media distribution via IBN to millions of social media followers.
For the broader healthcare industry, SS Innovations’ progress highlights how robotics and telecommunications are converging to reshape surgical care. If telesurgery continues to gain acceptance, it could help address surgeon shortages in remote areas and enable real-time collaboration across borders. However, regulatory clearances and clinical validation will remain key gates. The company’s pursuit of FDA clearance and CE marking will be watched closely as indicators of whether its cost-effective approach can scale in highly regulated markets. Terms of use and disclaimers for TechMediaWire content are available at https://www.TechMediaWire.com/Disclaimer.
